跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20 条关于
“RyboDyn”
全部
20
临床试验
0
药物
5
机构
1
资讯
14
去年
RyboDyn Expands Collaboration with Moffitt Cancer Center to Advance Novel "Dark Proteome" Cancer Immunotherapies
2个月前
RyboDyn Awarded $1.3M DOW Grant to Advance Novel Antibody Therapies Against Cryptic Lung Cancer Targets
2年前
CytoDyn Advances Leronlimab Pipeline Across Oncology, Inflammation, and HIV
去年
Leronlimab Shows Promise in Reversing Liver Fibrosis in Preclinical MASH Study
去年
Leronlimab Shows Promising Results in Reversing Liver Fibrosis, CytoDyn Reports
去年
Leronlimab-Based Immunotherapy Shows Promise for ART-Free HIV Control in Infant Macaques
去年
CytoDyn Appoints Dr. Melissa Palmer as Hepatology Lead and Advances Leronlimab Studies for MASH and Liver Fibrosis
去年
CytoDyn Receives FDA Clearance for Phase II Oncology Trial of Leronlimab in Colorectal Cancer
去年
CytoDyn Initiates Phase II Trial of Leronlimab in Relapsed/Refractory Colorectal Cancer
去年
CytoDyn Receives FDA Clearance for Phase II Trial of Leronlimab in Colorectal Cancer
第 1 页,共 2 页
上一页
下一页